Edition:
United States

Ophthotech Corp (OPHT.OQ)

OPHT.OQ on NASDAQ Stock Exchange Global Select Market

34.40USD
2 Dec 2016
Change (% chg)

$2.21 (+6.87%)
Prev Close
$32.19
Open
$32.47
Day's High
$35.28
Day's Low
$32.22
Volume
322,624
Avg. Vol
252,961
52-wk High
$80.00
52-wk Low
$29.86

OPHT.OQ

Chart for OPHT.OQ

About

Ophthotech Corporation is a biopharmaceutical company. The Company specializes in the development of therapeutics to treat diseases of the back of the eye, with a focus on developing therapeutics for age-related macular degeneration (AMD). Its advanced product candidate is Fovista, which is for use in combination with anti-vascu... (more)

Overall

Beta: --
Market Cap(Mil.): $1,289.04
Shares Outstanding(Mil.): 35.70
Dividend: --
Yield (%): --

Financials

  OPHT.OQ Industry Sector
P/E (TTM): -- 42.21 29.87
EPS (TTM): -4.60 -- --
ROI: -45.89 -1.09 14.95
ROE: -699.82 -2.39 16.29

BRIEF-Ophthotech Q3 loss per share $1.71

* Collaboration revenue was $1.7 million for quarter ended September 30, 2016, compared to $3.4 million for prior year period.

Nov 08 2016

BRIEF-Ophthotech Corp & Ajinomoto Althea entered into a clinical and commercial services agreement

* Ophthotech Corp - Co, Ajinomoto Althea, Inc. entered into a clinical and commercial services agreement - SEC filing

Nov 04 2016

BRIEF-Ophthotech Q2 loss per share $0.85

* Q2 earnings per share view $-1.05 -- Thomson Reuters I/B/E/S

Aug 03 2016

Competitors

Earnings vs. Estimates